Premier Fund Managers LTD Bristol Myers Squibb CO Transaction History

Premier Fund Managers LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $666,584 - $725,911	-10,767 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $12,995 - $14,616	-219 Reduced 1.99%	10,767 $682,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $8.65 Million - $9.81 Million	-149,864 Reduced 93.17%	10,986 $681,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $7.37 Million - $8.16 Million	128,250 Added 393.4%	160,850 $9.63 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $1.79 Million - $2.09 Million	32,600 New	32,600 $1.92 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Premier Fund Managers LTD with notifications on news.